Optimind Pharma Ratios and Metrics

Market cap in millions CAD. Fiscal year is March - February.

Millions CAD. Fiscal year is Mar - Feb.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Sep '24 Sep 24, 2024	Feb '24 Feb 29, 2024	Feb '23 Feb 28, 2023	Feb '22 Feb 28, 2022
Market Capitalization	1	0	4	-
Market Cap Growth	-59.90%	-87.47%	-	-
Enterprise Value	1	1	4	-
Last Close Price	0.01	0.01	0.04	-
PE Ratio	-	-0.36	-1.07	-
PS Ratio	5.34	3.99	23.01	-
PB Ratio	-4.33	-3.80	6.12	-
P/FCF Ratio	-9.00	-1.04	-3.76	-
P/OCF Ratio	-9.00	-1.04	-3.76	-
EV/Sales Ratio	5.41	8.37	21.79	-
EV/EBITDA Ratio	-	-1.39	-4.15	-
EV/EBIT Ratio	-3.20	-1.37	-4.09	-
EV/FCF Ratio	-13.95	-2.19	-3.56	-
Debt / Equity Ratio	-0.55	-0.97	0.96	0.04
Debt / FCF Ratio	-1.15	-0.27	-0.59	-0.57
Asset Turnover	0.14	0.15	0.07	-
Quick Ratio	0.42	0.51	1.07	2.04
Current Ratio	0.42	0.51	1.07	2.80
Return on Equity (ROE)	-1254.70%	-547.28%	-167.32%	-
Return on Assets (ROA)	-43.60%	-59.12%	-21.94%	-
Return on Capital (ROIC)	-63.91%	-75.34%	-25.63%	-
Earnings Yield	-209.38%	-284.95%	-78.65%	-
FCF Yield	-11.11%	-95.88%	-26.60%	-
Buyback Yield / Dilution	-16.04%	-21.38%	-88.09%	-
Total Shareholder Return	-16.04%	-21.38%	-88.09%	-

Source: S&P Capital IQ. Standard template. Financial Sources.